GPs urged to clarify RSV maternal vaccine rollout
18 Sep 2025
The RSV Mother and Infant Protection Program (RSV-MIPP), launched in February, provides free maternal RSV vaccines to pregnant women at 28–36 weeks gestation, helping protect newborns from severe illness. In April, programs for nirsevimab (Beyfortus), a long-acting monoclonal antibody for infants, became available nationwide, including in general practices.
Despite Australia leading in RSV prevention, Professor Hespe says confusion remains among healthcare providers due to a mix of National Immunisation Program (NIP) and state-funded programs, alongside guidance from the Australian Technical Advisory Group on Immunisation (ATAGI).
She highlights that three different RSV products are now available in Australia, each with slightly different approvals:
-
Maternal RSV vaccine – for pregnant women
-
Monoclonal antibody (Beyfortus) – for infants not protected by the maternal vaccine
-
RSV vaccine for older adults – not currently funded
“Understanding each product, offering the right one, and explaining it to patients is incredibly powerful,” Professor Hespe said.
She also emphasises the importance of clear labelling, storage, and administration in general practices to prevent errors. Practices should have separate, clearly marked systems for vaccines and monoclonal antibodies and ensure two staff check the correct product is given to the right patient.
Data shows that since the introduction of the vaccine and antibody, baby hospitalisations due to RSV have nearly halved in 2025 compared to last year.
Professor Hespe also urges GPs to:
-
Educate pregnant women about the protection the maternal RSV vaccine offers
-
Encourage older patients to be vaccinated, reducing community circulation of RSV
-
Ensure all pregnant patients are alerted to receive RSV vaccination alongside other recommended vaccines such as Boostrix
“GPs play a vital role in overseeing vaccination as part of holistic care. Your recommendation is key to ensuring patients get vaccinated,” she said.
Source: newsGP, September 2025
